Neuralink Corp., Elon Musk’s brain implant company, plans to launch a clinical trial in the US in October aiming to use its device to translate thoughts into text, potentially opening up new ...
OpenAI CEO Sam Altman has expressed concern about the content created by bots, which facilitate misinformation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback